NOV
53
-2
AMAT
41
-9
ADI
60
5
XYL
45
-7
AIG
48
-8
KIM
48
-6
EQIX
52
4
FE
53
-2
PEG
53
-2
NEM
69
-2
EBAY
56
3
XOM
42
3
PHM
37
2
FLR
43
10
LYB
41
7
VTR
60
5
CLX
62
-2
TAP
64
3
NWSA
88
10
PSA
46
-2
NOV
53
-2
AMAT
41
-9
ADI
60
5
XYL
45
-7
AIG
48
-8
KIM
48
-6
EQIX
52
4
FE
53
-2
PEG
53
-2
NEM
69
-2
EBAY
56
3
XOM
42
3
PHM
37
2
FLR
43
10
LYB
41
7
VTR
60
5
CLX
62
-2
TAP
64
3
NWSA
88
10
PSA
46
-2
Financhill
Back

Ascendis Pharma AS Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
58

ASND
Ascendis Pharma AS

Last Price:
$156.23
Seasonality Move:
1.98%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.31
Seasonality Move:
1.75%
Buy
58
Ascendis Pharma AS (ASND) is a Buy

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $144.08. The Score for ASND is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • ASND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $144.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.25 Buy
Relative Strength Index (14 RSI): 64.03 Buy
Chaikin Money Flow: -48652 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (122.87 - 134.51) Buy
Bollinger Bands (100): (125.13 - 139.39) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.38 Buy
20-day SMA: 127.8 Buy
50-day SMA: 132.19 Buy
200-day SMA: 132.5 Buy
8-day EMA: 131.54 Buy
20-day EMA: 129.61 Buy
50-day EMA: 130.67 Buy
200-day EMA: 130.98 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.38 per share, an increase this year of $3.07 per share, and an increase next year of $5.18 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):